NIH-funded research P01 program project

Immunity and heart-kidney health in adults

Official title: The intersection of immunity and cardiovascular diseases

Funded at Vanderbilt University Medical Center · NIH-11392993 · Data updated 2026-11-12

A large, patient-focused program will study how immune cells contribute to high blood pressure and autoimmune kidney and blood vessel disease in adults.

More Cardiovascular Diseases research and trials

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startAugust 15, 2025
Project endJuly 31, 2030
Funding year2026
Award (this year)$2,874,543
NIH project number5P01HL174442-02
Project IDNIH-11392993 on NIH RePORTER

Who could benefit from this research

Could help

Adults with hypertension or autoimmune conditions such as lupus or psoriasis may be eligible to participate.

Less likely to help

Some participants may not experience direct personal benefit, depending on the specific study arm and responses.

What this research studies

This project looks at how immune cells become activated and cause organ damage in hypertension and autoimmune diseases, with a focus on the kidneys and blood vessels. Researchers will study specific immune peptides and the way human HLAs present them, aiming to pinpoint T cells involved in hypertension, lupus, and psoriasis. They will test an approach to detect peptides that trigger T cells in people with high blood pressure and related conditions. In a separate effort, the team will explore how salt intake promotes harmful immune processes in humans and whether a four-week treatment can improve salt sensitivity and vascular health.

Why it matters

Potential benefit: If successful, the work could lead to new ways to prevent or treat kidney and blood vessel damage related to high blood pressure and autoimmune diseases.

How similar studies have gone: Previous research has shown immune mechanisms contributing to hypertension and autoimmune pathology, with growing evidence supporting targeted immune interventions.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Harrison, David G — Vanderbilt University Medical Center
  • Study coordinator: Harrison, David G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.